Gang Chen

10PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 05, 2026
Skeletal Muscle Metastasis in Patients With SMARCA4-Deficient Thoracic Tumors: A Retrospective Cohort Study.

|Dec 11, 2025
Anti-LAG-3 Antibody LBL-007 plus Tislelizumab and Chemotherapy as First-Line Therapy for Advanced Nasopharyngeal Carcinoma: A Multicenter Phase 2 Trial.

Dongchen Sun, Gang Chen, Yu Chen

|Apr 10, 2024
Chidamide plus envafolimab as subsequent treatment in advanced non-small cell lung cancer patients resistant to anti-PD-1 therapy: A multicohort, open-label, phase II trial with biomarker analysis.

Yaxiong Zhang, Zihong Chen, Yu Liu

|Jul 06, 2023
Predictive and prognostic role of early apolipoprotein A-I alteration in recurrent or metastatic nasopharyngeal carcinoma patients treated with anti-PD-1 therapy.

Bi Jing Xiao, Xiao Xian Sima, Gang Chen

|Jan 11, 2023
The maximum tumor growth rate predicts clinical outcomes of patients with small-cell lung cancer undergoing first-line chemotherapy plus immune-checkpoint inhibitor therapy.

Xiang Chen, Xueyuan Chen, Tingting Liu

|Feb 12, 2019
Docosapentaenoic acid and lung cancer risk: A Mendelian randomization study.

Jiaqing Liu, Huaqiang Zhou, Yaxiong Zhang

Pageof 2

Frequent Collaborators

3 joint publications

Shaodong Hong

3 joint publications

Ting Zhou

2 joint publications

Huaqiang Zhou

2 joint publications

Wei Xian